Search research articles
Contact Us
Filters
Showing results (161-170 of 251) with videos related to
Page
of 26
Sort By:
Archives of Toxicology
|
March 30, 2018
Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff?
Luigi Barrea, Giovanna Muscogiuri, Carolina Di Somma, et al.
The Journal of Dermatological Treatment
|
April 6, 2022
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Psoriasis (Auckland, N.Z.)
|
July 18, 2022
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
Matteo Megna, Luigi Fornaro, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology
|
March 21, 2023
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy
Sara Cacciapuoti, Emanuele Scala, Maria A Luciano, et al.
Italian Journal of Dermatology and Venereology
|
September 18, 2023
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy
Gaetano Licata, Vittorio Tancredi, Alessio Gambardella, et al.
Dermatology Practical & Conceptual
|
August 9, 2023
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, et al.
Experimental and Therapeutic Medicine
|
October 16, 2019
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment
Luisa Di Costanzo, Emanuele Scala, Giuseppina Caiazzo, et al.
Expert Opinion on Biological Therapy
|
June 16, 2025
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use
Matteo Megna, Giuseppe Lauletta, Michela D'Agostino, et al.
International Journal of Dermatology
|
February 14, 2017
The role of histological presentation in erythroderma
Matteo Megna, Akmal A Sidikov, Denis V Zaslavsky, et al.
The Australasian Journal of Dermatology
|
October 18, 2020
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?
Maria Vastarella, Matteo Megna, Gelsy Arianna Lupoli, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 251) with videos related to
Sort By:
Page
of 26
Archives of Toxicology
|
March 30, 2018
Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff?
Luigi Barrea, Giovanna Muscogiuri, Carolina Di Somma, et al.
The Journal of Dermatological Treatment
|
April 6, 2022
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Psoriasis (Auckland, N.Z.)
|
July 18, 2022
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
Matteo Megna, Luigi Fornaro, Luca Potestio, et al.
Italian Journal of Dermatology and Venereology
|
March 21, 2023
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy
Sara Cacciapuoti, Emanuele Scala, Maria A Luciano, et al.
Italian Journal of Dermatology and Venereology
|
September 18, 2023
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy
Gaetano Licata, Vittorio Tancredi, Alessio Gambardella, et al.
Dermatology Practical & Conceptual
|
August 9, 2023
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire
Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, et al.
Experimental and Therapeutic Medicine
|
October 16, 2019
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment
Luisa Di Costanzo, Emanuele Scala, Giuseppina Caiazzo, et al.
Expert Opinion on Biological Therapy
|
June 16, 2025
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use
Matteo Megna, Giuseppe Lauletta, Michela D'Agostino, et al.
International Journal of Dermatology
|
February 14, 2017
The role of histological presentation in erythroderma
Matteo Megna, Akmal A Sidikov, Denis V Zaslavsky, et al.
The Australasian Journal of Dermatology
|
October 18, 2020
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?
Maria Vastarella, Matteo Megna, Gelsy Arianna Lupoli, et al.
Page
of 26